Table 3.
Parameters used to develop the machine learning models.
| Parameters | All (N = 46) |
Selected mode 1 (n = 36) |
Selected mode 2 (n = 20) |
|---|---|---|---|
| Male sex | ✓ | ✓ | ✓ |
| Age | ✓ | ✓ | ✓ |
| Platelet | ✓ | ✓ | ✓ |
| Albumin | ✓ | ✓ | ✓ |
| Total bilirubin | ✓ | ✓ | ✓ |
| ALT | ✓ | ✓ | ✓ |
| AST | ✓ | ||
| Alpha-foetoprotein | ✓ | ||
| International normalized ratio | ✓ | ||
| Creatinine | ✓ | ||
| Gamma glutamyl transferase | ✓ | ||
| Total cholesterol | ✓ | ||
| HbA1c | ✓ | ||
| Fasting glucose | ✓ | ||
| HBV DNA | ✓ | ||
| Positive HBeAg | ✓ | ||
| Cirrhosis | ✓ | ✓ | ✓ |
| Cardiovascular disease | ✓ | ✓ | |
| Colorectal cancer | ✓ | ✓ | |
| Lung cancers | ✓ | ✓ | |
| Urinary/renal malignancies | ✓ | ✓ | |
| Cervical cancer | ✓ | ✓ | |
| Breast cancer | ✓ | ✓ | |
| Lymphoma | ✓ | ✓ | |
| Chronic kidney disease | ✓ | ✓ | ✓ |
| Osteopenia | ✓ | ✓ | |
| Osteoporosis | ✓ | ✓ | |
| Diabetes mellitus | ✓ | ✓ | ✓ |
| Hypertension | ✓ | ✓ | ✓ |
| Anticoagulants | ✓ | ✓ | |
| ACEI/ARB | ✓ | ✓ | ✓ |
| Antiplatelet agents | ✓ | ✓ | ✓ |
| Beta blockers | ✓ | ✓ | ✓ |
| Histamine-2 receptor antagonist | ✓ | ✓ | |
| Insulin | ✓ | ✓ | ✓ |
| Immunosuppressant | ✓ | ✓ | |
| Loop diuretics | ✓ | ✓ | |
| Metformin | ✓ | ✓ | ✓ |
| NSAID | ✓ | ✓ | |
| Other lipid-lowering agents | ✓ | ✓ | ✓ |
| Other oral hypoglycaemic agents | ✓ | ✓ | ✓ |
| Proton pump inhibitor | ✓ | ✓ | ✓ |
| Potassium sparing diuretics | ✓ | ✓ | |
| Statins | ✓ | ✓ | ✓ |
| Sulphonylurea | ✓ | ✓ | ✓ |
| Thiazides | ✓ | ✓ |
ACEI, angiotensin-converting-enzyme inhibitor; ALT, alanine aminotransferase; ARB, angiotensin receptor blocker; AST, aspartate aminotransferase; CTP, Child–Turcotte–Pugh; HbA1c, haemoglobin A1c.